Skip to main content

Table 2 Antimicrobial susceptibility profiles for invasive and noninvasive S agalactiae isolates

From: Emerging trends in invasive and noninvasive isolates of Streptococcus agalactiaein a Latin American hospital: a 17-year study

Antibiotic

1994-2001S. agalactiaesusceptibility (%)

2004-2012S. agalactiaesusceptibility (%)

 

Invasive

Noninvasive

Invasive

Noninvasive

Ampicillin

100

98.3

95.4

99.1

Penicillin

100

97.5

96.3*

99

Clindamycin

93

94.5

90.7

91.4

Erythromycin

97.5

97

85.3

88.2

Levofloxacin

-

-

96.9

97.6

Tetracycline

21.4

8.1

9.4

11.9

Vancomycin

100

100

100

99.6

Linezolid

-

-

100

100

  1. *p = 0.02.